How large is the vertebroplasty and kyphoplasty market, and what is its growth trajectory?
The vertebroplasty & kyphoplasty market size has grown strongly in recent years. It will grow from $0.97 billion in 2024 to $1.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to aging population and osteoporosis prevalence, advancements in minimally invasive techniques, rising awareness and diagnosis, increasing lifestyle-related factors, growing burden on healthcare systems.
The vertebroplasty & kyphoplasty market size is expected to see strong growth in the next few years. It will grow to $1.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to expansion of geriatric care services, development of biocompatible bone cement, increased adoption of outpatient procedures, focus on value-based healthcare, growing geriatric population. Major trends in the forecast period include research and development in spinal interventions, expansion of ambulatory surgical centers, technological innovations in bone cement, technological advancements in procedures, healthcare cost containment and reimbursement challenges.
Get Your Free Sample of The Global Vertebroplasty And Kyphoplasty Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13556&type=smp
What are the key forces behind the vertebroplasty and kyphoplasty market’s growth in recent years?
The rise in the incidence of spinal injuries related to sports injuries is expected to propel the growth of the vertebroplasty and kyphoplasty markets going forward. Spinal injuries related to sports injuries are damage to the spine that occurs as a result of participating in sports or other physical activities. The surge in sports-related spinal injuries encompasses conditions such as vertebral compression fractures, spondylolisthesis, and herniated discs that require minimally invasive treatment options such as vertebroplasty and kyphoplasty procedures, involving the injection of bone cement into damaged vertebrae. For instance, in November 2023, according to the New Zealand Spinal Trust, a New Zealand-based disability services and support organization, according to the 2022 NZSCIR data, the incidence rate in New Zealand is now 45 per million, a modest rise from 41 per million in 2021 and comparable to the 44 per million recorded in 2020. In 2022, males represented 74% of individuals with traumatic spinal cord injury (tSCI), while females comprised 33% of those with non-traumatic spinal cord injury (NTSCI). Therefore, the rise in the incidence of spinal injuries related to sports injuries will drive the growth of the vertebroplasty and kyphoplasty market.
What are the major segments of the vertebroplasty and kyphoplasty market?
The vertebroplasty and kyphoplasty market covered in this report is segmented –
1) By Product Type: Kyphoplasty Devices, Vertebroplasty Devices
2) By Surgery Type: Vertebroplastic Surgery, Kyphoplastic Surgery
3) By End User: Hospitals, Ambulatory Surgical Centers
Subsegments:
1) By Kyphoplasty Devices: Balloon Kyphoplasty Devices, Inflation Devices, Vertebral Restoration Devices
2) By Vertebroplasty Devices: Bone Cement Delivery Systems, Cannulas and Needles
3) By Spinal Biopsy Devices: Spinal Biopsy Devices
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/vertebroplasty-and-kyphoplasty-global-market-report
Which companies dominate the vertebroplasty and kyphoplasty market?
Major companies operating in the vertebroplasty and kyphoplasty market report are Cardinal Health, Johnson and Johnson (DePuy Synthes), Medtronic Plc., Stryker Corporation, GS Solutions Inc., Lepu Medical Technology (Beijing)Co.Ltd., Merit Medical Systems Inc., Globus Medical Inc., Alphatec Spine Inc., Rontis Corporation, Spectrum Plastics Group., SOMATEX Medical Technologies GmbH, Zavation LLC, MJ Surgical, Benvenue Medical, Joimax GmbH, Laurane Medical LLC, Spine Wave Inc., G21 S.r.l., BM Korea Co. Ltd., Biopsybell Medical, Teknimed, Joline GmbH And Co. KG, SCW Medicath Ltd., Stöckli Medical AG, Jiangsu ChangMei Medtech Co.Ltd., IZI Medical Products
What major trends will shape the vertebroplasty and kyphoplasty market during the forecast period?
Major companies operating in the vertebroplasty and kyphoplasty market are adopting a strategic partnership approach to provide the unipedicular balloon catheter for the treatment of compression fractures of the vertebrae. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in June 2024, Medtronic Plc, an Ireland-based medical technology company, partnered with Merit Medical Systems Inc. a US-based medical device company. As a result of this partnership, a unipedicular, steerable balloon catheter will be developed for the treatment of vertebral compression fractures (VCF) in the United States. This agreement builds on the existing collaboration between Medtronic and Merit, with Merit already providing Medtronic’s Kyphon Xpander Inflation Syringes for balloon kyphoplasty procedures. The Kyphon KyphoFlex is engineered to enable controlled, precise, and targeted cavity creation during vertebral augmentation. The introduction of this unipedicular solution will complement Medtronic’s current bipedicular balloon kyphoplasty offering, enhancing flexibility and options for clinicians.
What are the key regional dynamics of the vertebroplasty and kyphoplasty market, and which region leads in market share?
North America was the largest region in the vertebroplasty and kyphoplasty market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty and kyphoplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Vertebroplasty And Kyphoplasty Market Report 2025 Offer?
The vertebroplasty and kyphoplasty market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Vertebroplasty and kyphoplasty are minimally invasive surgical procedures used to treat non-healing vertebral compression fractures (VCFs) in the spine. These methods involve the injection of polymethyl methacrylate (PMMA) into the vertebral body for structural reinforcement.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13556
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
